Associate Professor Giovanni Strippoli

Adjunct Associate Professor
Public Health, School of Public Health

Telephone +393358756828
Fax +390994595340

Map

Selected grants

2007

  • Effects of dose of erythropoiesis stimulating agents on cardiac-cerebrovascular outcomes and quality; Tognoni G, Triolo G, Craig J, Procaccini D, Alloatti S, Nicolucci A, Strippoli G; Agenzia Italiana Del Farmaco/Research Support.

2006

  • Cardio-renal effects of renin angiotensin system inhibition in cardio-renal patients; Palasciano G, Gesualdo L, Strippoli G, Craig J, Tognoni G, Nicolucci A, Pellegrini F; Agenzia Italiana Del Farmaco/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Strippoli, G., Wiggins, K., Johnson, D., Navaneethan, S., Cancarini, G., Craig, J. (2009). Prevention and Treatment of Peritoneal Dialysis-Related Infections. In D. Molony and J. Craig (Eds.), Evidence-based Nephrology, (pp. 509-532). West Sussex, UK: Wiley-Blackwell Publishing.

Journals

  • Nistor, I., Palmer, S., Craig, J., Saglimbene, V., Vecchio, M., Covic, A., Strippoli, G. (2014). Convective Versus Diffusive Dialysis Therapies for Chronic Kidney Failure: An Updated Systematic Review of Randomized Controlled Trials. American Journal of Kidney Diseases, 63(6), 954-967. [More Information]
  • Palmer, S., Saglimbene, V., Craig, J., Navaneethan, S., Strippoli, G. (2014). Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database of Systematic Reviews, 2014 (3), 1-112. [More Information]
  • Palmer, S., Wong, G., Iff, S., Yang, J., Jayaswal, V., Craig, J., Rochtchina, E., Mitchell, P., Wang, J., Strippoli, G. (2014). Fluid intake and all-cause mortality, cardiovascular mortality, and kidney function: a population-based longitudinal cohort study. Nephrology, Dialysis, Transplantation, 29(7), 1377-1384. [More Information]
  • Palmer, S., Navaneethan, S., Craig, J., Johnson, D., Perkovic, V., Hegbrant, J., Strippoli, G. (2014). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, 5, CD007784. [More Information]
  • Palmer, S., Strippoli, G., Craig, J. (2014). KHA-CARI commentary on the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease. Nephrology, 19(11), 663-666. [More Information]
  • Palmer, S., De Berardis, G., Craig, J., Tong, A., Tonelli, M., Pellegrini, F., Ruospo, M., Hegbrant, J., Wollheim, C., Celia, E., Strippoli, G., et al (2014). Patient satisfaction with in-centre haemodialysis care: an international survey. BMJ Open, 4(5), 1-9. [More Information]
  • Ruospo, M., Palmer, S., Craig, J., Gentile, G., Johnson, D., Ford, P., Tonelli, M., Petruzzi, M., De Benedittis, M., Strippoli, G. (2014). Prevalence and severity of oral disease in adults with chronic kidney disease: A systematic review of observational studies. Nephrology, Dialysis, Transplantation, 29(2), 364-375. [More Information]
  • Kabani, R., Quinn, R., Palmer, S., Lewin, A., Yilmaz, S., Tibbles, L., Lorenzetti, D., Strippoli, G., McLaughlin, K., Ravani, P. (2014). Risk of death following kidney allograft failure: a systematic review and meta-analysis of cohort studies. Nephrology, Dialysis, Transplantation, 29(9), 1778-1786. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Perkovic, V., Pellegrini, F., Jardine, M., Webster, A., Zoungas, S., Strippoli, G., et al (2013). Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews, 2013 (4), 1-136. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Ravani, P., Perkovic, V., Tognoni, G., Graziano, G., Jardine, M., Pellegrini, F., Webster, A., Strippoli, G., et al (2013). Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis. American Journal of Kidney Diseases, 61(1), 112-122. [More Information]
  • Hodson, E., Ladhani, M., Webster, A., Strippoli, G., Craig, J. (2013). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, 2, 1-198. [More Information]
  • Palmer, S., Vecchio, M., Craig, J., Tonelli, M., Johnson, D., Nicolucci, A., Pellegrini, F., Saglimbene, V., Logroscino, G., Hedayati, S., Strippoli, G. (2013). Association Between Depression and Death in People With CKD: A Meta-analysis of Cohort Studies. American Journal of Kidney Diseases, 62(3), 493-505. [More Information]
  • Ravani, P., Palmer, S., Oliver, M., Quinn, R., MacRae, J., Tai, D., Pannu, N., Thomas, C., Hemmelgarn, B., Craig, J., Strippoli, G., et al (2013). Associations between hemodialysis access type and clinical outcomes: a systematic review. Journal of the American Society of Nephrology, 24(3), 465-473. [More Information]
  • Palmer, S., Strippoli, G. (2013). Calcimimetics and other simple pharmacological interventions do not work in dialysis: what can we do about it? Journal of Nephrology, 26(4), 599-602. [More Information]
  • Palmer, S., Nistor, I., Craig, J., Pellegrini, F., Messa, P., Tonelli, M., Covic, A., Strippoli, G. (2013). Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Medicine, 10(4), 1-13. [More Information]
  • Lv, J., Ehteshami, P., Sarnak, M., Tighiouart, H., Jun, M., Ninomiya, T., Foote, C., Rodgers, A., Zhang, H., Wang, H., Strippoli, G., Perkovic, V. (2013). Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ - Canadian Medical Association Journal, 185(11), 949-957. [More Information]
  • Palmer, S., Navaneethan, S., Craig, J., Johnson, D., Perkovic, V., Nigwekar, S., Hegbrant, J., Strippoli, G. (2013). HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews, 2013 (9), 1-81. [More Information]
  • Cho, Y., Johnson, D., Badve, S., Craig, J., Strippoli, G., Wiggins, K. (2013). Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials. Nephrology, Dialysis, Transplantation, 28(7), 1899-1907. [More Information]
  • Henderson, L., Masson, P., Craig, J., Roberts, M., Flanc, R., Strippoli, G., Webster, A. (2013). Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials. American Journal of Kidney Diseases, 61(1), 74-87. [More Information]
  • Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G., Pellegrini, F., Nicolucci, A. (2013). Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review. PloS One, 8(8), 1-12. [More Information]
  • Strippoli, G., Palmer, S., Ruospo, M., Natale, P., Saglimbene, V., Craig, J., Pellegrini, F., Petruzzi, M., De Benedittis, M., Ford, P., et al (2013). Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study. BMC Nephrology, 14(1), 1-10. [More Information]
  • Owers, D., Webster, A., Strippoli, G., Kable, K., Hodson, E. (2013). Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, 2013 (2), 1-81. [More Information]
  • Palmer, S., Vecchio, M., Craig, J., Tonelli, M., Johnson, D., Nicolucci, A., Pellegrini, F., Saglimbene, V., Logroscino, G., Fishbane, S., Strippoli, G. (2013). Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney International, 84(1), 179-191. [More Information]
  • Tong, A., Palmer, S., Manns, B., Craig, J., Ruospo, M., Gargano, L., Johnson, D., Hegbrant, J., Olsson, M., Fishbane, S., Strippoli, G. (2013). The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study. BMJ Open, 3(1), 1-15. [More Information]
  • Cho, Y., Johnson, D., Badve, S., Craig, J., Strippoli, G., Wiggins, K. (2013). The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney International, 84(5), 969-979. [More Information]
  • Nigwekar, S., Strippoli, G., Navaneethan, S. (2013). Thyroid hormones for acute kidney injury. Cochrane Database of Systematic Reviews, 1, 1-23. [More Information]
  • Pilotto, A., Sancarlo, D., Aucella, F., Fontana, A., Addante, F., Copetti, M., Panza, F., Strippoli, G., Ferrucci, L. (2012). Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease. Rejuvenation Research, 15(1), 82-88. [More Information]
  • Lv, J., Perkovic, V., Foote, C., Craig, M., Craig, J., Strippoli, G. (2012). Antihypertensive agents for preventing diabetic kidney disease (Review). Cochrane Database of Systematic Reviews, (12), 1-90. [More Information]
  • Palmer, S., Craig, J., Navaneethan, S., Tonelli, M., Pellegrini, F., Strippoli, G. (2012). Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Annals of Internal Medicine, 157(4), 263-275. [More Information]
  • Tong, A., Palmer, S., Manns, B., Craig, J., Ruospo, M., Gargano, L., Johnson, D., Hegbrant, J., Olsson, M., Fishbane, S., Strippoli, G. (2012). Clinician beliefs and attitudes about home haemodialysis: a multinational interview study. BMJ Open, 2(6), 1-12. [More Information]
  • Vecchio, M., Palmer, S., Tonelli, M., Johnson, D., Strippoli, G. (2012). Depression and sexual dysfunction in chronic kidney disease: A narrative review of the evidence in areas of significant unmet need. Nephrology, Dialysis, Transplantation, 27(9), 3420-3428. [More Information]
  • Maggi, P., Montinaro, V., Bellacosa, C., Pietanza, S., Volpe, A., Graziano, G., Strippoli, G., Angarano, G. (2012). Early Markers of Tubular Dysfunction in Antiretroviral-Experienced HIV-Infected Patients Treated with Tenofovir Versus Abacavir. AIDS Patient Care and STDs, 26(1), 5-11. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Perkovic, V., Pellegrini, F., Copetti, M., Graziano, G., Tognoni, G., Jardine, M., Webster, A., Strippoli, G., et al (2012). Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis. Annals of Internal Medicine, 156(6), 445-459. [More Information]
  • Ludovico, O., Farina, M., Copetti, M., Palena, A., Proto, V., Marotta, V., Strippoli, G., Frittitta, L., Trischitta, V., Prudente, S. (2012). ENPP1 mRNA levels in white blood cells and prediction of metformin efficacy in type 2 diabetic patients: a preliminary evidence. Nutrition, Metabolism & Cardiovascular Diseases, 22(2), e5-e6. [More Information]
  • Palmer, S., Rabindranath, K., Craig, J., Roderick, P., Locatelli, F., Strippoli, G. (2012). High-flux versus low-flux membranes for end-stage kidney disease (Review). Cochrane Database of Systematic Reviews, 9, 1-115. [More Information]
  • Vecchio, M., Palmer, S., De Berardis, G., Craig, J., Johnson, D., Pellegrini, F., Nicolucci, A., Sciancalepore, M., Saglimbene, V., Gargano, L., Strippoli, G., et al (2012). Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: A multinational cross-sectional study. Nephrology, Dialysis, Transplantation, 27(6), 2479-2488. [More Information]
  • Fishbane, S., Hazzan, A., Shirazian, S., Israel, E., Strippoli, G. (2012). Quality of reporting of randomization methodology in nephrology trials. Kidney International, 82(11), 1144-1146. [More Information]
  • Vecchio, M., Palmer, S., De Berardis, G., Craig, J., Lucisano, G., Johnson, D., Pellegrini, F., Nicolucci, A., Sciancalepore, M., Saglimbene, V., Strippoli, G., et al (2012). Sexual dysfunction in women with ESRD requiring hemodialysis. Clinical Journal of the American Society of Nephrology, 7(6), 974-981. [More Information]
  • Jardine, M., Kang, A., Zoungas, S., Navaneethan, S., Ninomiya, T., Nigwekar, S., Gallagher, M., Cass, A., Strippoli, G., Perkovic, V. (2012). The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ, 344(7863), 1-11. [More Information]
  • Henderson, L., Masson, P., Craig, J., Flanc, R., Roberts, M., Strippoli, G., Webster, A. (2012). Treatment for lupus nephritis (Review). Cochrane Database of Systematic Reviews, 12, 1-226. [More Information]
  • Maione, A., Navaneethan, S., Graziano, G., Mitchell, R., Johnson, D., Mann, J., Gao, P., Craig, J., Tognoni, G., Perkovic, V., Strippoli, G., et al (2011). Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials. Nephrology, Dialysis, Transplantation, 26(9), 2827-2847. [More Information]
  • Strippoli, G., Craig, J., Rochtchina, E., Flood, V., Wang, J., Mitchell, P. (2011). Fluid and nutrient intake and risk of chronic kidney disease. Nephrology, 16(3), 326-334. [More Information]
  • Reid, S., Cawthon, P., Craig, J., Samuels, J., Molony, D., Strippoli, G. (2011). Non-immunosuppressive treatment for IgA nephropathy. Cochrane Database of Systematic Reviews, 2011 (3), CD003962-1-CD003962-166. [More Information]
  • Navaneethan, S., Palmer, S., Vecchio, M., Craig, J., Elder, G., Strippoli, G. (2011). Phosphate binders for preventing and treating bone disease in chronic kidney disease patients (Review). Cochrane Database of Systematic Reviews, 2011 (2), CD006023-1-CD006023-143. [More Information]
  • Navaneethan, S., Hegbrandt, J., Strippoli, G. (2011). Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease. Current Opinion In Nephrology And Hypertension, 20(2), 146-152. [More Information]
  • Palmer, S., Hayen, A., Macaskill, P., Pellegrini, F., Craig, J., Elder, G., Strippoli, G. (2011). Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease. JAMA: The Journal of the American Medical Association, 305(11), 1119-1127. [More Information]
  • Gentile, G., Strippoli, G. (2011). Should we shift toward higher blood pressure targets in patients with chronic kidney disease? Journal of Nephrology, 24(6), 673-685. [More Information]
  • Razavian, M., Di Micco, L., Palmer, S., Craig, J., Perkovic, V., Zoungas, S., Webster, A., Jardine, M., Strippoli, G. (2010). Antiplatelet agents for chronic kidney disease (Protocol). Cochrane Database of Systematic Reviews, 2010 (11), 1-16. [More Information]
  • Quintaliani, G., Gambirasio, C., Strippoli, G. (2010). Ci Sono Differenze Nel Trattamento Del Nefropatico Se Il Paziente È Ricoverato In Medicina O In Nefrologia? Sì le differenze sono notevoli (Are there differences in the treatment of kidney patients if they are admitted to general medicine vs nephrology units? Yes, and they are significant). Giornale Italiano di Nefrologia (GIN), 27(1), 10-19. [More Information]
  • Zsom, L., Zsom, M., Fulop, T., Wells, C., Flessner, M., Eller, J., Wollheim, C., Hegbrant, J., Strippoli, G. (2010). Correlation of treatment time and ultrafiltration rate with serum albumin and C-reactive protein levels in patients with end-stage kidney disease receiving chronic maintenance hemodialysis: a cross-sectional study. Blood Purification, 30(1), 8-15. [More Information]
  • Saglimbene, V., Maione, A., Vecchio, M., Nicolucci, A., Pellegrini, F., Navaneethan, S., Palmer, S., Craig, J., Triolo, G., Procaccini, D., Strippoli, G., et al (2010). Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol. Trials, 11, 1-7. [More Information]
  • Smith, A., Palmer, S., Johnson, D., Navaneethan, S., Valentini, M., Strippoli, G. (2010). How to conduct a randomized trial. Nephrology, 15(8), 740-746. [More Information]
  • Navaneethan, S., Palmer, S., Smith, A., Johnson, D., Strippoli, G. (2010). How to design a randomised controlled trial. Nephrology, 15(8), 732-739. [More Information]
  • Palmer, S., Navaneethan, S., Strippoli, G. (2010). How to read a nephrology systematic review. Nephrology, 15(2), 158-164. [More Information]
  • Palmer, S., Strippoli, G. (2010). How to read critically a prognostic cohort study. Nephrology, 15(7), 676-682. [More Information]
  • Vecchio, M., Navaneethan, S., Johnson, D., Lucisano, G., Graziano, G., Saglimbene, V., Ruospo, M., Querques, M., Jannini, E., Strippoli, G. (2010). Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database of Systematic Reviews, 12(CD007747), CD007747-1-CD007747-53. [More Information]
  • Palmer, S., Navaneethan, S., Craig, J., Johnson, D., Tonelli, M., Garg, A., Pellegrini, F., Ravani, P., Jardine, M., Perkovic, V., Strippoli, G., et al (2010). Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease. Annals of Internal Medicine, 153(1), 23-34. [More Information]
  • Navaneethan, S., Vecchio, M., Johnson, D., Saglimbene, V., Graziano, G., Pellegrini, F., Lucisano, G., Craig, J., Ruospo, M., Gentile, G., Strippoli, G., et al (2010). Prevalence and Correlates of Self-Reported Sexual Dysfunction in CKD: A Meta-analysis of Observational Studies. American Journal of Kidney Diseases, 56(4), 670-685. [More Information]
  • Vecchio, M., Navaneethan, S., Johnson, D., Lucisano, G., Graziano, G., Querques, M., Saglimbene, V., Ruospo, M., Bonifati, C., Jannini, E., Strippoli, G. (2010). Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clinical Journal of the American Society of Nephrology, 5(6), 985-995. [More Information]
  • Navaneethan, S., Nigwekar, S., Sehgal, A., Strippoli, G. (2009). Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews, Article number CD007004(3), 1-39. [More Information]
  • Navaneethan, S., Nigwekar, S., Sehgal, A., Strippoli, G. (2009). Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis. Clinical Journal of the American Society of Nephrology, 4, 542-551. [More Information]
  • De Berardis, G., Sacco, M., Strippoli, G., Pellegrini, F., Graziano, G., Tognoni, G., Nicolucci, A. (2009). Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. British Medical Journal, 339(b4531), 8. [More Information]
  • Navaneethan, S., Palmer, S., Craig, J., Elder, G., Strippoli, G. (2009). Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. American Journal of Kidney Diseases, 54(4), 619-637. [More Information]
  • Navaneethan, S., Nigwekar, S., Perkovic, V., Johnson, D., Craig, J., Strippoli, G. (2009). HMG CoA reductase inhibitors (statins) for dialysis patients (Review). Cochrane Database of Systematic Reviews, Article number CD004289(3), 1-39. [More Information]
  • Navaneethan, S., Perkovic, V., Johnson, D., Nigwekar, S., Craig, J., Strippoli, G. (2009). HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database of Systematic Reviews, Article number CD005019(2), 1-30. [More Information]
  • Navaneethan, S., Pansini, F., Perkovic, V., Manno, C., Pellegrini, F., Johnson, D., Craig, J., Strippoli, G. (2009). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, Article number CD007784(2), 1-48. [More Information]
  • Strippoli, G., Maione, A., Schena, F., Tognoni, G., Craig, J. (2009). IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice. American Journal of Kidney Diseases, 53(1), 5-8. [More Information]
  • Nigwekar, S., Cass, A., Gallagher, M., Jardine, M., Kang, A., Kulshrestha, S., Navaneethan, S., Perkovic, V., Strippoli, G., Zoungas, S. (2009). Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database of Systematic Reviews, 2(2 (Art. No.: CD004683)), 1-12. [More Information]
  • Kang, A., Nigwekar, S., Perkovic, V., Kulshrestha, S., Zoungas, S., Navaneethan, S., Cass, A., Gallagher, M., Ninomiya, T., Strippoli, G., et al (2009). Interventions for lowering plasma homocysteine levels in kidney transplant recipients [Protocol]. Cochrane Database of Systematic Reviews, (3), 1-12. [More Information]
  • Maione, A., Strippoli, G. (2009). Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade. Ethnicity and Disease, 19(1), S1-86-9. [More Information]
  • Strippoli, G., Craig, J. (2009). Sunset for Statins after AURORA? New England Journal of Medicine, 360(14), 1455-1457. [More Information]
  • Palmer, S., Craig, J., Strippoli, G. (2009). Taking aim at targets. Nephrology, Dialysis, Transplantation, 24(5), 1358-1361. [More Information]
  • Palmer, S., McGregor, D., Craig, J., Elder, G., Macaskill, P., Strippoli, G. (2009). Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, Article number CD008175(4), 1-47.
  • Palmer, S., McGregor, D., Craig, J., Elder, G., Macaskill, P., Strippoli, G. (2009). Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews, Pages CD005633(4), 1-120.
  • Navaneethan, S., Palmer, S., Schreiber, M., Strippoli, G. (2009). Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder. Nephrology, 14(4), 363-366. [More Information]
  • Hodson, E., Craig, J., Webster, A., Strippoli, G. (2008). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, (2), 1-118. [More Information]
  • Alloatti, S., Strippoli, G., Buccianti, G., Daidone, G., Schena, F. (2008). Current structure and organization for renal patient assistance in Italy. Nephrology, Dialysis, Transplantation, 23(4), 1323-1329. [More Information]
  • Strippoli, G., Navaneethan, S., Perkovic, V., Pellegrini, F., Nicolucci, A., Johnson, D., Craig, J. (2008). Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ: British Medical Journal, 336(7645), 1-14. [More Information]
  • Bonifati, C., Strippoli, G., Manno, C., Schena, F. (2008). Evidence-based guidelines and nephrological clinical practice: the GRADE system for rating of evidence. Giornale Italiano di Nefrologia (GIN), 25(4), 449-458. [More Information]
  • Navaneethan, S., Viswanathan, G., Strippoli, G. (2008). Meta-analysis of mycophenolate mofetil in IgA nephropathy. Nephrology, 13(1), 90. [More Information]
  • Santoro, A., Mancini, E., Bolzani, R., Boggi, R., Cagnoli, L., Francioso, A., Fusaroli, M., Piazza, V., Rapana, R., Strippoli, G. (2008). The Effect of On-line High-flux Hemofiltration Versus Low-flux Hemodialysis on Mortality in Chronic Kidney Failure: A Small Randomized Controlled Trial. American Journal of Kidney Diseases, 52(3), 507-518. [More Information]
  • Wiggins, K., Craig, J., Johnson, D., Strippoli, G. (2008). Treatment for peritoneal dialysis-associated peritonitis (Review). Cochrane Database of Systematic Reviews, CD005284, 1-119. [More Information]
  • Navaneethan, S., Viswanathan, G., Strippoli, G. (2008). Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs, 68(15), 2095-2104. [More Information]
  • Manno, C., Strippoli, G., D'Altri, C., Torres, D., Rossini, M., Schena, F. (2007). A Novel Simpler Histological Classification for Renal Survival in IgA Nephropathy: A Retrospective Study. American Journal of Kidney Diseases, 49(6), 763-775. [More Information]
  • Walker, R., Strippoli, G. (2007). A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate. The Lancet, 370(9596), 1395-6. [More Information]
  • Maione, A., Nicolucci, A., Craig, J., Tognoni, G., Moschetta, A., Palasciano, G., Pugliese, G., Procaccini, D., Gesualdo, L., Pellegrini, F., Strippoli, G. (2007). ACE-inibizione, antagonismo recettoriale e terapia combinata in soggetti microalbuminurici con fattori di rischio cardiovascolare. Protocollo dello studio randomizzato multicentrico LIRICO (Long-term Impact of RAS Inhibition on Cardiorenal Outcomes). Giornale Italiano di Nefrologia (GIN), 24(5), 446-456.
  • Maione, A., Nicolucci, A., Craig, J., Tognoni, G., Moschetta, A., Palasciano, G., Pugliese, G., Procaccini, D., Gesualdo, L., Pellegrini, F., Strippoli, G., et al (2007). Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO). Giornale Italiano di Nefrologia (GIN), 24(5), 446-456. [More Information]
  • Strippoli, G., Tognoni, G., Navaneethan, S., Nicolucci, A., Craig, J. (2007). Comment: Haemoglobin targets: we were wrong, time to move on. The Lancet, 369(9559), 346-350.
  • Strippoli, G., Tognoni, G., Navaneethan, S., Nicolucci, A., Craig, J. (2007). Haemoglobin targets: we were wrong, time to move on. The Lancet, 369(9559), 346-350. [More Information]
  • Franciosi, M., Pellegrini, F., Sacco, M., De Berardis, G., Rossi, M., Strippoli, G., Belfiglio, M., Tognoni, G., Valentini, M., Nicolucci, A., et al (2007). Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clinical Journal of the American Society of Nephrology, 2. [More Information]
  • Hodson, E., Jones, C., Strippoli, G., Webster, A., Craig, J. (2007). Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, Cochrane Database of Systematic Reviews 2007(Issue 2. Art. No.: CD005129), 1-101. [More Information]
  • Palmer, S., McGregor, D., Macaskill, P., Craig, J., Elder, G., Strippoli, G. (2007). Meta-analysis: vitamin D compounds in chronic kidney disease. Annals of Internal Medicine, 147(12), 840-853. [More Information]
  • Maione, A., Nicolucci, A., Craig, J., Tognoni, G., Moschetta, A., Palasciano, G., Pugliese, G., Procaccini, D., Gesualdo, L., Pellegrini, F., Strippoli, G. (2007). Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial. Journal of Nephrology, 20(6), 646-655. [More Information]
  • Palmer, S., Craig, J., Strippoli, G. (2007). Sevelamer: a promising but unproven drug. Nephrology, Dialysis, Transplantation, 22(10), 2742-2745. [More Information]
  • Wiggins, K., Johnson, D., Craig, J., Strippoli, G. (2007). Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials. American Journal of Kidney Diseases, 50(6), 967-988. [More Information]
  • Logan, T., Strippoli, G., Levine, M. (2007). Urticaria and angioedema in renal cell cancer patients treated with IL-2. Cancer Investigation, 25(7), 584-588. [More Information]
  • Strippoli, G., Bonifati, C., Craig, M., Navaneethan, S., Craig, J. (2006). Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database of Systematic Reviews, 18(4), CD006257-CD006257. [More Information]
  • Navaneethan, S., Querques, M., Bonifati, C., Strippoli, G. (2006). Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection. The Diabetes Educator, 32(4), 596-602. [More Information]
  • Bonifati, C., Pansini, F., Torres, D., Navaneethan, S., Craig, J., Strippoli, G. (2006). Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice. International Journal of Artificial Organs, 29(1), 41-49. [More Information]
  • Strippoli, G., Tong, A., Palmer, S., Elder, G., Craig, J. (2006). Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database of Systematic Reviews, 18(4), CD006254-CD006254. [More Information]
  • Navaneethan, S., Bonifati, C., Schena, F., Strippoli, G. (2006). Evidence for optimal hemoglobin targets in chronic kidney disease. Journal of Nephrology, 19(5), 640-647. [More Information]
  • Strippoli, G., Navaneethan, S., Craig, J. (2006). Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database of Systematic Reviews, 18(4), CD003967-CD003967. [More Information]
  • Strippoli, G., Palmer, S., Tong, A., Elder, G., Messa, P., Craig, J. (2006). Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy. American Journal of Kidney Diseases, 47(5), 715-726. [More Information]
  • Strippoli, G., Jones, C., Craig, J., Smith, G. (2006). Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, 25(1), CD005133-CD005133. [More Information]
  • Strippoli, G., Craig, M., Schena, F., Craig, J. (2006). Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. Journal of the American Society of Nephrology, 17(4), S153-S155. [More Information]
  • Navaneethan, S., Pansini, F., Strippoli, G. (2006). Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials. PLoS Medicine, 3(5), e123 - 0615-e123 - 0618. [More Information]
  • Strippoli, G., Craig, M., Craig, J. (2005). Antihypertensive agents for preventing diabetic kidney disease (Review). Cochrane Database of Systematic Reviews, 1(4), 1-46. [More Information]
  • Strippoli, G., Craig, M., Schena, F., Craig, J. (2005). Antihypertensive agents for primary prevention of diabetic nephropathy. Journal of the American Society of Nephrology, 16(10), 3081-3091. [More Information]
  • Hodson, E., Craig, J., Strippoli, G., Webster, A. (2005). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, , 1-143. [More Information]
  • Hodson, E., Jones, C., Webster, A., Strippoli, G., Barclay, P., Kable, K., Vimalachandra, D., Craig, J. (2005). Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. The Lancet, 365(9477), 2105-2115. [More Information]
  • Hodson, E., Jones, C., Webster, A., Strippoli, G., Craig, J. (2005). Antiviral treatment after solid organ transplantation (Authors' reply). The Lancet, 366(9488), 807.
  • Rabindranath, K., Strippoli, G., Roderick, P., Wallace, S., MacLeod, A., Daly, C. (2005). Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. American Journal of Kidney Diseases, 45(3), 437-447. [More Information]
  • Strippoli, G., Craig, J. (2005). Hypothesis versus association: the optimal hemoglobin target debate (Editorial). American Journal of Kidney Diseases, 46(5), 970-973. [More Information]
  • Palmer, S., Strippoli, G., McGregor, D. (2005). Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. American Journal of Kidney Diseases, 45(4), 638-649. [More Information]
  • Huynh, S., Kifley, A., Strippoli, G., Mitchell, P. (2005). Is renal impairment a predictor of the incidence of cataract or cataract surgery? Findings from a population-based study. Ophthalmology, 112(2), 293-300. [More Information]
  • Strippoli, G., Tong, A., Johnson, D., Schena, F., Craig, J. (2004). Antimicrobial Agents For Preventing Peritonitis In Peritoneal Dialysis Patients. Cochrane Database of Systematic Reviews, 4, 1-79.
  • Strippoli, G., Tong, A., Johnson, D., Schena, F., Craig, J. (2004). Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trial. American Journal of Kidney Diseases, 44(4), 591-603.
  • Strippoli, G., Tong, A., Johnson, D., Schena, F., Craig, J. (2004). Catheter related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Journal of the American Society of Nephrology, 15(10), 2735-2746. [More Information]
  • Strippoli, G., Tong, A., Johnson, D., Schena, F., Craig, J. (2004). Catheter Type, Placement And Insertion Techniques For Preventing Peritonitis In Peritoneal Dialysis Patients (Review). Cochrane Database of Systematic Reviews, 4, 1-54.
  • Strippoli, G., Tong, A., Johnson, D., Craig, J., Schena, F. (2004). Catheter-Related Interventions To Prevent Peritonitis In Peritoneal Dialysis: A Systematic Review Of Randomized, Controlled Trials. Journal of the American Society of Nephrology, 15(10), 2735-2746.
  • Strippoli, G., Jonathan, C. (2004). Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers to prevent end-stage kidney disease in patients who do not have diabetes. Medical Journal of Australia, 181(8). [More Information]
  • Strippoli, G., Craig, M., Deeks, J., Schena, F., Craig, J. (2004). Effects Of Angiotensin Converting Enzyme Inhibitors And Angiotensin Ii Receptor Antagonists On Mortality And Renal Outcomes In Diabetic Nephropathy: Systematic Review. BMJ: British Medical Journal, 329 (7470)(828), 1-11.
  • Craig, J., Strippoli, G., Manno, C., Schena, F. (2004). Hemoglobin Targets For The Anemia Of Chronic Kidney Disease: A Meta-Analysis Of Randomized, Controlled Trials. Journal of the American Society of Nephrology, 15(12), 3154-3165.
  • Samuels, J., Schena, F., Strippoli, G., Craig, J., Molony, D. (2004). Immunosuppressive Treatments For Immunoglobin A Nephropathy: A Meta-Analysis Of Randomized Controlled Trials. Nephrology, 9(4), 177-185.
  • Samuels, J., Strippoli, G., Craig, J., Schena, F., Molony, D. (2004). Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology, 9(4), 177-185. [More Information]
  • Manno, C., Strippoli, G., Arnesano, L., Bonifati, C., Campobasso, N., Gesualdo, L., Schena, F. (2004). Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney International, 66(4), 1570-1577. [More Information]
  • Gesualdo, L., Di Palma, A., Morrone, L., Strippoli, G., Schena, F. (2004). The Italian experience of the national registry of renal biopsies. Kidney International, 66(3), 890-894. [More Information]
  • Strippoli, G., Craig, J., Schena, F. (2004). The Number, Quality And Coverage Of Randomized Controlled Trials In Nephrology. Journal of the American Society of Nephrology, 15(2), 411-419.
  • Flanc, R., Roberts, M., Strippoli, G., Chadban, S., Kerr, P., Atkins, R. (2004). Treatment For Lupus Nephritis. Cochrane Database of Systematic Reviews, 1(CD002922), 1-79.
  • Flanc, R., Roberts, M., Strippoli, G., Chadban, S., Kerr, P., Atkins, R. (2004). Treatment Of Diffuse Proliferative Lupus Nephritis: A Meta-Analysis Of Randomized Controlled Trials. American Journal of Kidney Diseases, 43(2), 197-208.
  • Strippoli, G., Manno, C., Schena, F. (2003). An "evidence-based" survey of therapeutic options for IgA nephropathy: Assessment and criticism. American Journal of Kidney Diseases, 41(6), 1129-1139. [More Information]
  • Strippoli, G., Manno, C., Schena, F., Craig, J. (2003). Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. Cochrane Database of Systematic Reviews, CD003967(1), 1-77.
  • Samuels, J., Strippoli, G., Craig, J., Schena, F., Molony, D. (2003). Immunosuppressive agents for treating IgA nephropathy. Cochrane Database of Systematic Reviews, 4(Issue 4), 1-51. [More Information]
  • Strippoli, G., Craig, M., Schena, F., Craig, J., et, A. (2003). Improved survival with ACE inhibitors compared with angiotensin II receptor antagonists in patients with diabetic nephropathy. Journal of the American Society of Nephrology, 14, 6A-6A.
  • Strippoli, G., Craig, J., Manno, C., et, A. (2002). Hemoglobin and hematocrit targets for the anemia of chronic renal failure: A systematic review of randomized trials. Journal of the American Society of Nephrology, 13, 632A.
  • Strippoli, G., Craig, J., Manno, C., et, A. (2002). Nephrology and randomized trials: Are we asking intervention questions? Are we asking them right? Journal of the American Society of Nephrology, 13, 4A.

Conferences

  • Navaneethan, S., Craig, J., Strippoli, G. (2006). High versus low hemoglobin for patient level outcomes in anemia of chronic kidney disease patients: Update of a Cochrane review. XLIII ERA-EDTA congress.
  • Torres, D., Strippoli, G., Palmer, S., Schena, F., Craig, J. (2006). Predictive value of microabluminuria and proteinuria on cardiovascular and renal survival: A systematic review of cohort studies. XLIII ERA-EDTA congress.
  • Torres, D., Strippoli, G., Palmer, S., Schena, F., Craig, J. (2006). Predictive value of microalbuminuria and proteinuria on cardiovascular and renal survival: A systematic review of cohort studies. XLIII ERA-EDTA Congress, United Kingdom: Oxford University Press.
  • Strippoli, G., Bonifati, C., Craig, M., Schena, F., Craig, J. (2005). Antihypertensive agents for primary prevention of diabetic nephropathy: with focus on renal outcomes, is it proven that any agent is equivalent, as long as blood pressure control is tight? XLII Congress of the ERA-EDTA, United Kingdom: Oxford University Press.
  • Strippoli, G., Craig, J., Rochtchina, E., Mitchell, P. (2005). Dialysis - nutrition, malnutrition, oxidative stress, inflammation 2: Poster (SP352) Daily intake of water, magnesium and carbohidrates associated with the development of renal impairment in the elderly. XLII Congress of the ERA-EDTA, United Kingdom: Oxford University Press.
  • Strippoli, G., Craig, M., Schena, F., Craig, J. (2003). Delaying the progression of diabetic nephropathy with antihypertensive agents: a meta-analysis of randomised trials. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Strippoli, G., Craig, J., Craig, M., Schena, F. (2002). Antihypertensive agents for preventing diabetic nephropathy and retarding its progression: a systematic review of randomized controlled trials [RCTs]. 3rd Annual Scientific Meeting of the Australian and New Zealand Association of Clinical Anatomists, Melbourne: La Trobe University.
  • Strippoli, G., Craig, J., Manno, C., Pertosa, G., Schena, F. (2002). Targets of anemia treatment in chronic renal failure. 3rd Annual Scientific Meeting of the Australian and New Zealand Association of Clinical Anatomists, Melbourne: La Trobe University.

2014

  • Nistor, I., Palmer, S., Craig, J., Saglimbene, V., Vecchio, M., Covic, A., Strippoli, G. (2014). Convective Versus Diffusive Dialysis Therapies for Chronic Kidney Failure: An Updated Systematic Review of Randomized Controlled Trials. American Journal of Kidney Diseases, 63(6), 954-967. [More Information]
  • Palmer, S., Saglimbene, V., Craig, J., Navaneethan, S., Strippoli, G. (2014). Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database of Systematic Reviews, 2014 (3), 1-112. [More Information]
  • Palmer, S., Wong, G., Iff, S., Yang, J., Jayaswal, V., Craig, J., Rochtchina, E., Mitchell, P., Wang, J., Strippoli, G. (2014). Fluid intake and all-cause mortality, cardiovascular mortality, and kidney function: a population-based longitudinal cohort study. Nephrology, Dialysis, Transplantation, 29(7), 1377-1384. [More Information]
  • Palmer, S., Navaneethan, S., Craig, J., Johnson, D., Perkovic, V., Hegbrant, J., Strippoli, G. (2014). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, 5, CD007784. [More Information]
  • Palmer, S., Strippoli, G., Craig, J. (2014). KHA-CARI commentary on the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease. Nephrology, 19(11), 663-666. [More Information]
  • Palmer, S., De Berardis, G., Craig, J., Tong, A., Tonelli, M., Pellegrini, F., Ruospo, M., Hegbrant, J., Wollheim, C., Celia, E., Strippoli, G., et al (2014). Patient satisfaction with in-centre haemodialysis care: an international survey. BMJ Open, 4(5), 1-9. [More Information]
  • Ruospo, M., Palmer, S., Craig, J., Gentile, G., Johnson, D., Ford, P., Tonelli, M., Petruzzi, M., De Benedittis, M., Strippoli, G. (2014). Prevalence and severity of oral disease in adults with chronic kidney disease: A systematic review of observational studies. Nephrology, Dialysis, Transplantation, 29(2), 364-375. [More Information]
  • Kabani, R., Quinn, R., Palmer, S., Lewin, A., Yilmaz, S., Tibbles, L., Lorenzetti, D., Strippoli, G., McLaughlin, K., Ravani, P. (2014). Risk of death following kidney allograft failure: a systematic review and meta-analysis of cohort studies. Nephrology, Dialysis, Transplantation, 29(9), 1778-1786. [More Information]

2013

  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Perkovic, V., Pellegrini, F., Jardine, M., Webster, A., Zoungas, S., Strippoli, G., et al (2013). Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews, 2013 (4), 1-136. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Ravani, P., Perkovic, V., Tognoni, G., Graziano, G., Jardine, M., Pellegrini, F., Webster, A., Strippoli, G., et al (2013). Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis. American Journal of Kidney Diseases, 61(1), 112-122. [More Information]
  • Hodson, E., Ladhani, M., Webster, A., Strippoli, G., Craig, J. (2013). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, 2, 1-198. [More Information]
  • Palmer, S., Vecchio, M., Craig, J., Tonelli, M., Johnson, D., Nicolucci, A., Pellegrini, F., Saglimbene, V., Logroscino, G., Hedayati, S., Strippoli, G. (2013). Association Between Depression and Death in People With CKD: A Meta-analysis of Cohort Studies. American Journal of Kidney Diseases, 62(3), 493-505. [More Information]
  • Ravani, P., Palmer, S., Oliver, M., Quinn, R., MacRae, J., Tai, D., Pannu, N., Thomas, C., Hemmelgarn, B., Craig, J., Strippoli, G., et al (2013). Associations between hemodialysis access type and clinical outcomes: a systematic review. Journal of the American Society of Nephrology, 24(3), 465-473. [More Information]
  • Palmer, S., Strippoli, G. (2013). Calcimimetics and other simple pharmacological interventions do not work in dialysis: what can we do about it? Journal of Nephrology, 26(4), 599-602. [More Information]
  • Palmer, S., Nistor, I., Craig, J., Pellegrini, F., Messa, P., Tonelli, M., Covic, A., Strippoli, G. (2013). Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Medicine, 10(4), 1-13. [More Information]
  • Lv, J., Ehteshami, P., Sarnak, M., Tighiouart, H., Jun, M., Ninomiya, T., Foote, C., Rodgers, A., Zhang, H., Wang, H., Strippoli, G., Perkovic, V. (2013). Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ - Canadian Medical Association Journal, 185(11), 949-957. [More Information]
  • Palmer, S., Navaneethan, S., Craig, J., Johnson, D., Perkovic, V., Nigwekar, S., Hegbrant, J., Strippoli, G. (2013). HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews, 2013 (9), 1-81. [More Information]
  • Cho, Y., Johnson, D., Badve, S., Craig, J., Strippoli, G., Wiggins, K. (2013). Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials. Nephrology, Dialysis, Transplantation, 28(7), 1899-1907. [More Information]
  • Henderson, L., Masson, P., Craig, J., Roberts, M., Flanc, R., Strippoli, G., Webster, A. (2013). Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials. American Journal of Kidney Diseases, 61(1), 74-87. [More Information]
  • Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G., Pellegrini, F., Nicolucci, A. (2013). Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review. PloS One, 8(8), 1-12. [More Information]
  • Strippoli, G., Palmer, S., Ruospo, M., Natale, P., Saglimbene, V., Craig, J., Pellegrini, F., Petruzzi, M., De Benedittis, M., Ford, P., et al (2013). Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study. BMC Nephrology, 14(1), 1-10. [More Information]
  • Owers, D., Webster, A., Strippoli, G., Kable, K., Hodson, E. (2013). Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, 2013 (2), 1-81. [More Information]
  • Palmer, S., Vecchio, M., Craig, J., Tonelli, M., Johnson, D., Nicolucci, A., Pellegrini, F., Saglimbene, V., Logroscino, G., Fishbane, S., Strippoli, G. (2013). Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney International, 84(1), 179-191. [More Information]
  • Tong, A., Palmer, S., Manns, B., Craig, J., Ruospo, M., Gargano, L., Johnson, D., Hegbrant, J., Olsson, M., Fishbane, S., Strippoli, G. (2013). The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study. BMJ Open, 3(1), 1-15. [More Information]
  • Cho, Y., Johnson, D., Badve, S., Craig, J., Strippoli, G., Wiggins, K. (2013). The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney International, 84(5), 969-979. [More Information]
  • Nigwekar, S., Strippoli, G., Navaneethan, S. (2013). Thyroid hormones for acute kidney injury. Cochrane Database of Systematic Reviews, 1, 1-23. [More Information]

2012

  • Pilotto, A., Sancarlo, D., Aucella, F., Fontana, A., Addante, F., Copetti, M., Panza, F., Strippoli, G., Ferrucci, L. (2012). Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease. Rejuvenation Research, 15(1), 82-88. [More Information]
  • Lv, J., Perkovic, V., Foote, C., Craig, M., Craig, J., Strippoli, G. (2012). Antihypertensive agents for preventing diabetic kidney disease (Review). Cochrane Database of Systematic Reviews, (12), 1-90. [More Information]
  • Palmer, S., Craig, J., Navaneethan, S., Tonelli, M., Pellegrini, F., Strippoli, G. (2012). Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Annals of Internal Medicine, 157(4), 263-275. [More Information]
  • Tong, A., Palmer, S., Manns, B., Craig, J., Ruospo, M., Gargano, L., Johnson, D., Hegbrant, J., Olsson, M., Fishbane, S., Strippoli, G. (2012). Clinician beliefs and attitudes about home haemodialysis: a multinational interview study. BMJ Open, 2(6), 1-12. [More Information]
  • Vecchio, M., Palmer, S., Tonelli, M., Johnson, D., Strippoli, G. (2012). Depression and sexual dysfunction in chronic kidney disease: A narrative review of the evidence in areas of significant unmet need. Nephrology, Dialysis, Transplantation, 27(9), 3420-3428. [More Information]
  • Maggi, P., Montinaro, V., Bellacosa, C., Pietanza, S., Volpe, A., Graziano, G., Strippoli, G., Angarano, G. (2012). Early Markers of Tubular Dysfunction in Antiretroviral-Experienced HIV-Infected Patients Treated with Tenofovir Versus Abacavir. AIDS Patient Care and STDs, 26(1), 5-11. [More Information]
  • Palmer, S., Di Micco, L., Razavian, M., Craig, J., Perkovic, V., Pellegrini, F., Copetti, M., Graziano, G., Tognoni, G., Jardine, M., Webster, A., Strippoli, G., et al (2012). Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis. Annals of Internal Medicine, 156(6), 445-459. [More Information]
  • Ludovico, O., Farina, M., Copetti, M., Palena, A., Proto, V., Marotta, V., Strippoli, G., Frittitta, L., Trischitta, V., Prudente, S. (2012). ENPP1 mRNA levels in white blood cells and prediction of metformin efficacy in type 2 diabetic patients: a preliminary evidence. Nutrition, Metabolism & Cardiovascular Diseases, 22(2), e5-e6. [More Information]
  • Palmer, S., Rabindranath, K., Craig, J., Roderick, P., Locatelli, F., Strippoli, G. (2012). High-flux versus low-flux membranes for end-stage kidney disease (Review). Cochrane Database of Systematic Reviews, 9, 1-115. [More Information]
  • Vecchio, M., Palmer, S., De Berardis, G., Craig, J., Johnson, D., Pellegrini, F., Nicolucci, A., Sciancalepore, M., Saglimbene, V., Gargano, L., Strippoli, G., et al (2012). Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: A multinational cross-sectional study. Nephrology, Dialysis, Transplantation, 27(6), 2479-2488. [More Information]
  • Fishbane, S., Hazzan, A., Shirazian, S., Israel, E., Strippoli, G. (2012). Quality of reporting of randomization methodology in nephrology trials. Kidney International, 82(11), 1144-1146. [More Information]
  • Vecchio, M., Palmer, S., De Berardis, G., Craig, J., Lucisano, G., Johnson, D., Pellegrini, F., Nicolucci, A., Sciancalepore, M., Saglimbene, V., Strippoli, G., et al (2012). Sexual dysfunction in women with ESRD requiring hemodialysis. Clinical Journal of the American Society of Nephrology, 7(6), 974-981. [More Information]
  • Jardine, M., Kang, A., Zoungas, S., Navaneethan, S., Ninomiya, T., Nigwekar, S., Gallagher, M., Cass, A., Strippoli, G., Perkovic, V. (2012). The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ, 344(7863), 1-11. [More Information]
  • Henderson, L., Masson, P., Craig, J., Flanc, R., Roberts, M., Strippoli, G., Webster, A. (2012). Treatment for lupus nephritis (Review). Cochrane Database of Systematic Reviews, 12, 1-226. [More Information]

2011

  • Maione, A., Navaneethan, S., Graziano, G., Mitchell, R., Johnson, D., Mann, J., Gao, P., Craig, J., Tognoni, G., Perkovic, V., Strippoli, G., et al (2011). Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials. Nephrology, Dialysis, Transplantation, 26(9), 2827-2847. [More Information]
  • Strippoli, G., Craig, J., Rochtchina, E., Flood, V., Wang, J., Mitchell, P. (2011). Fluid and nutrient intake and risk of chronic kidney disease. Nephrology, 16(3), 326-334. [More Information]
  • Reid, S., Cawthon, P., Craig, J., Samuels, J., Molony, D., Strippoli, G. (2011). Non-immunosuppressive treatment for IgA nephropathy. Cochrane Database of Systematic Reviews, 2011 (3), CD003962-1-CD003962-166. [More Information]
  • Navaneethan, S., Palmer, S., Vecchio, M., Craig, J., Elder, G., Strippoli, G. (2011). Phosphate binders for preventing and treating bone disease in chronic kidney disease patients (Review). Cochrane Database of Systematic Reviews, 2011 (2), CD006023-1-CD006023-143. [More Information]
  • Navaneethan, S., Hegbrandt, J., Strippoli, G. (2011). Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease. Current Opinion In Nephrology And Hypertension, 20(2), 146-152. [More Information]
  • Palmer, S., Hayen, A., Macaskill, P., Pellegrini, F., Craig, J., Elder, G., Strippoli, G. (2011). Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease. JAMA: The Journal of the American Medical Association, 305(11), 1119-1127. [More Information]
  • Gentile, G., Strippoli, G. (2011). Should we shift toward higher blood pressure targets in patients with chronic kidney disease? Journal of Nephrology, 24(6), 673-685. [More Information]

2010

  • Razavian, M., Di Micco, L., Palmer, S., Craig, J., Perkovic, V., Zoungas, S., Webster, A., Jardine, M., Strippoli, G. (2010). Antiplatelet agents for chronic kidney disease (Protocol). Cochrane Database of Systematic Reviews, 2010 (11), 1-16. [More Information]
  • Quintaliani, G., Gambirasio, C., Strippoli, G. (2010). Ci Sono Differenze Nel Trattamento Del Nefropatico Se Il Paziente È Ricoverato In Medicina O In Nefrologia? Sì le differenze sono notevoli (Are there differences in the treatment of kidney patients if they are admitted to general medicine vs nephrology units? Yes, and they are significant). Giornale Italiano di Nefrologia (GIN), 27(1), 10-19. [More Information]
  • Zsom, L., Zsom, M., Fulop, T., Wells, C., Flessner, M., Eller, J., Wollheim, C., Hegbrant, J., Strippoli, G. (2010). Correlation of treatment time and ultrafiltration rate with serum albumin and C-reactive protein levels in patients with end-stage kidney disease receiving chronic maintenance hemodialysis: a cross-sectional study. Blood Purification, 30(1), 8-15. [More Information]
  • Saglimbene, V., Maione, A., Vecchio, M., Nicolucci, A., Pellegrini, F., Navaneethan, S., Palmer, S., Craig, J., Triolo, G., Procaccini, D., Strippoli, G., et al (2010). Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol. Trials, 11, 1-7. [More Information]
  • Smith, A., Palmer, S., Johnson, D., Navaneethan, S., Valentini, M., Strippoli, G. (2010). How to conduct a randomized trial. Nephrology, 15(8), 740-746. [More Information]
  • Navaneethan, S., Palmer, S., Smith, A., Johnson, D., Strippoli, G. (2010). How to design a randomised controlled trial. Nephrology, 15(8), 732-739. [More Information]
  • Palmer, S., Navaneethan, S., Strippoli, G. (2010). How to read a nephrology systematic review. Nephrology, 15(2), 158-164. [More Information]
  • Palmer, S., Strippoli, G. (2010). How to read critically a prognostic cohort study. Nephrology, 15(7), 676-682. [More Information]
  • Vecchio, M., Navaneethan, S., Johnson, D., Lucisano, G., Graziano, G., Saglimbene, V., Ruospo, M., Querques, M., Jannini, E., Strippoli, G. (2010). Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database of Systematic Reviews, 12(CD007747), CD007747-1-CD007747-53. [More Information]
  • Palmer, S., Navaneethan, S., Craig, J., Johnson, D., Tonelli, M., Garg, A., Pellegrini, F., Ravani, P., Jardine, M., Perkovic, V., Strippoli, G., et al (2010). Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease. Annals of Internal Medicine, 153(1), 23-34. [More Information]
  • Navaneethan, S., Vecchio, M., Johnson, D., Saglimbene, V., Graziano, G., Pellegrini, F., Lucisano, G., Craig, J., Ruospo, M., Gentile, G., Strippoli, G., et al (2010). Prevalence and Correlates of Self-Reported Sexual Dysfunction in CKD: A Meta-analysis of Observational Studies. American Journal of Kidney Diseases, 56(4), 670-685. [More Information]
  • Vecchio, M., Navaneethan, S., Johnson, D., Lucisano, G., Graziano, G., Querques, M., Saglimbene, V., Ruospo, M., Bonifati, C., Jannini, E., Strippoli, G. (2010). Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clinical Journal of the American Society of Nephrology, 5(6), 985-995. [More Information]

2009

  • Navaneethan, S., Nigwekar, S., Sehgal, A., Strippoli, G. (2009). Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews, Article number CD007004(3), 1-39. [More Information]
  • Navaneethan, S., Nigwekar, S., Sehgal, A., Strippoli, G. (2009). Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis. Clinical Journal of the American Society of Nephrology, 4, 542-551. [More Information]
  • De Berardis, G., Sacco, M., Strippoli, G., Pellegrini, F., Graziano, G., Tognoni, G., Nicolucci, A. (2009). Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. British Medical Journal, 339(b4531), 8. [More Information]
  • Navaneethan, S., Palmer, S., Craig, J., Elder, G., Strippoli, G. (2009). Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. American Journal of Kidney Diseases, 54(4), 619-637. [More Information]
  • Navaneethan, S., Nigwekar, S., Perkovic, V., Johnson, D., Craig, J., Strippoli, G. (2009). HMG CoA reductase inhibitors (statins) for dialysis patients (Review). Cochrane Database of Systematic Reviews, Article number CD004289(3), 1-39. [More Information]
  • Navaneethan, S., Perkovic, V., Johnson, D., Nigwekar, S., Craig, J., Strippoli, G. (2009). HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database of Systematic Reviews, Article number CD005019(2), 1-30. [More Information]
  • Navaneethan, S., Pansini, F., Perkovic, V., Manno, C., Pellegrini, F., Johnson, D., Craig, J., Strippoli, G. (2009). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, Article number CD007784(2), 1-48. [More Information]
  • Strippoli, G., Maione, A., Schena, F., Tognoni, G., Craig, J. (2009). IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice. American Journal of Kidney Diseases, 53(1), 5-8. [More Information]
  • Nigwekar, S., Cass, A., Gallagher, M., Jardine, M., Kang, A., Kulshrestha, S., Navaneethan, S., Perkovic, V., Strippoli, G., Zoungas, S. (2009). Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database of Systematic Reviews, 2(2 (Art. No.: CD004683)), 1-12. [More Information]
  • Kang, A., Nigwekar, S., Perkovic, V., Kulshrestha, S., Zoungas, S., Navaneethan, S., Cass, A., Gallagher, M., Ninomiya, T., Strippoli, G., et al (2009). Interventions for lowering plasma homocysteine levels in kidney transplant recipients [Protocol]. Cochrane Database of Systematic Reviews, (3), 1-12. [More Information]
  • Strippoli, G., Wiggins, K., Johnson, D., Navaneethan, S., Cancarini, G., Craig, J. (2009). Prevention and Treatment of Peritoneal Dialysis-Related Infections. In D. Molony and J. Craig (Eds.), Evidence-based Nephrology, (pp. 509-532). West Sussex, UK: Wiley-Blackwell Publishing.
  • Maione, A., Strippoli, G. (2009). Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade. Ethnicity and Disease, 19(1), S1-86-9. [More Information]
  • Strippoli, G., Craig, J. (2009). Sunset for Statins after AURORA? New England Journal of Medicine, 360(14), 1455-1457. [More Information]
  • Palmer, S., Craig, J., Strippoli, G. (2009). Taking aim at targets. Nephrology, Dialysis, Transplantation, 24(5), 1358-1361. [More Information]
  • Palmer, S., McGregor, D., Craig, J., Elder, G., Macaskill, P., Strippoli, G. (2009). Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, Article number CD008175(4), 1-47.
  • Palmer, S., McGregor, D., Craig, J., Elder, G., Macaskill, P., Strippoli, G. (2009). Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews, Pages CD005633(4), 1-120.
  • Navaneethan, S., Palmer, S., Schreiber, M., Strippoli, G. (2009). Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder. Nephrology, 14(4), 363-366. [More Information]

2008

  • Hodson, E., Craig, J., Webster, A., Strippoli, G. (2008). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, (2), 1-118. [More Information]
  • Alloatti, S., Strippoli, G., Buccianti, G., Daidone, G., Schena, F. (2008). Current structure and organization for renal patient assistance in Italy. Nephrology, Dialysis, Transplantation, 23(4), 1323-1329. [More Information]
  • Strippoli, G., Navaneethan, S., Perkovic, V., Pellegrini, F., Nicolucci, A., Johnson, D., Craig, J. (2008). Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ: British Medical Journal, 336(7645), 1-14. [More Information]
  • Bonifati, C., Strippoli, G., Manno, C., Schena, F. (2008). Evidence-based guidelines and nephrological clinical practice: the GRADE system for rating of evidence. Giornale Italiano di Nefrologia (GIN), 25(4), 449-458. [More Information]
  • Navaneethan, S., Viswanathan, G., Strippoli, G. (2008). Meta-analysis of mycophenolate mofetil in IgA nephropathy. Nephrology, 13(1), 90. [More Information]
  • Santoro, A., Mancini, E., Bolzani, R., Boggi, R., Cagnoli, L., Francioso, A., Fusaroli, M., Piazza, V., Rapana, R., Strippoli, G. (2008). The Effect of On-line High-flux Hemofiltration Versus Low-flux Hemodialysis on Mortality in Chronic Kidney Failure: A Small Randomized Controlled Trial. American Journal of Kidney Diseases, 52(3), 507-518. [More Information]
  • Wiggins, K., Craig, J., Johnson, D., Strippoli, G. (2008). Treatment for peritoneal dialysis-associated peritonitis (Review). Cochrane Database of Systematic Reviews, CD005284, 1-119. [More Information]
  • Navaneethan, S., Viswanathan, G., Strippoli, G. (2008). Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs, 68(15), 2095-2104. [More Information]

2007

  • Manno, C., Strippoli, G., D'Altri, C., Torres, D., Rossini, M., Schena, F. (2007). A Novel Simpler Histological Classification for Renal Survival in IgA Nephropathy: A Retrospective Study. American Journal of Kidney Diseases, 49(6), 763-775. [More Information]
  • Walker, R., Strippoli, G. (2007). A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate. The Lancet, 370(9596), 1395-6. [More Information]
  • Maione, A., Nicolucci, A., Craig, J., Tognoni, G., Moschetta, A., Palasciano, G., Pugliese, G., Procaccini, D., Gesualdo, L., Pellegrini, F., Strippoli, G. (2007). ACE-inibizione, antagonismo recettoriale e terapia combinata in soggetti microalbuminurici con fattori di rischio cardiovascolare. Protocollo dello studio randomizzato multicentrico LIRICO (Long-term Impact of RAS Inhibition on Cardiorenal Outcomes). Giornale Italiano di Nefrologia (GIN), 24(5), 446-456.
  • Maione, A., Nicolucci, A., Craig, J., Tognoni, G., Moschetta, A., Palasciano, G., Pugliese, G., Procaccini, D., Gesualdo, L., Pellegrini, F., Strippoli, G., et al (2007). Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO). Giornale Italiano di Nefrologia (GIN), 24(5), 446-456. [More Information]
  • Strippoli, G., Tognoni, G., Navaneethan, S., Nicolucci, A., Craig, J. (2007). Comment: Haemoglobin targets: we were wrong, time to move on. The Lancet, 369(9559), 346-350.
  • Strippoli, G., Tognoni, G., Navaneethan, S., Nicolucci, A., Craig, J. (2007). Haemoglobin targets: we were wrong, time to move on. The Lancet, 369(9559), 346-350. [More Information]
  • Franciosi, M., Pellegrini, F., Sacco, M., De Berardis, G., Rossi, M., Strippoli, G., Belfiglio, M., Tognoni, G., Valentini, M., Nicolucci, A., et al (2007). Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clinical Journal of the American Society of Nephrology, 2. [More Information]
  • Hodson, E., Jones, C., Strippoli, G., Webster, A., Craig, J. (2007). Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, Cochrane Database of Systematic Reviews 2007(Issue 2. Art. No.: CD005129), 1-101. [More Information]
  • Palmer, S., McGregor, D., Macaskill, P., Craig, J., Elder, G., Strippoli, G. (2007). Meta-analysis: vitamin D compounds in chronic kidney disease. Annals of Internal Medicine, 147(12), 840-853. [More Information]
  • Maione, A., Nicolucci, A., Craig, J., Tognoni, G., Moschetta, A., Palasciano, G., Pugliese, G., Procaccini, D., Gesualdo, L., Pellegrini, F., Strippoli, G. (2007). Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial. Journal of Nephrology, 20(6), 646-655. [More Information]
  • Palmer, S., Craig, J., Strippoli, G. (2007). Sevelamer: a promising but unproven drug. Nephrology, Dialysis, Transplantation, 22(10), 2742-2745. [More Information]
  • Wiggins, K., Johnson, D., Craig, J., Strippoli, G. (2007). Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials. American Journal of Kidney Diseases, 50(6), 967-988. [More Information]
  • Logan, T., Strippoli, G., Levine, M. (2007). Urticaria and angioedema in renal cell cancer patients treated with IL-2. Cancer Investigation, 25(7), 584-588. [More Information]

2006

  • Strippoli, G., Bonifati, C., Craig, M., Navaneethan, S., Craig, J. (2006). Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database of Systematic Reviews, 18(4), CD006257-CD006257. [More Information]
  • Navaneethan, S., Querques, M., Bonifati, C., Strippoli, G. (2006). Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection. The Diabetes Educator, 32(4), 596-602. [More Information]
  • Bonifati, C., Pansini, F., Torres, D., Navaneethan, S., Craig, J., Strippoli, G. (2006). Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice. International Journal of Artificial Organs, 29(1), 41-49. [More Information]
  • Strippoli, G., Tong, A., Palmer, S., Elder, G., Craig, J. (2006). Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database of Systematic Reviews, 18(4), CD006254-CD006254. [More Information]
  • Navaneethan, S., Bonifati, C., Schena, F., Strippoli, G. (2006). Evidence for optimal hemoglobin targets in chronic kidney disease. Journal of Nephrology, 19(5), 640-647. [More Information]
  • Strippoli, G., Navaneethan, S., Craig, J. (2006). Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database of Systematic Reviews, 18(4), CD003967-CD003967. [More Information]
  • Navaneethan, S., Craig, J., Strippoli, G. (2006). High versus low hemoglobin for patient level outcomes in anemia of chronic kidney disease patients: Update of a Cochrane review. XLIII ERA-EDTA congress.
  • Strippoli, G., Palmer, S., Tong, A., Elder, G., Messa, P., Craig, J. (2006). Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy. American Journal of Kidney Diseases, 47(5), 715-726. [More Information]
  • Strippoli, G., Jones, C., Craig, J., Smith, G. (2006). Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systematic Reviews, 25(1), CD005133-CD005133. [More Information]
  • Torres, D., Strippoli, G., Palmer, S., Schena, F., Craig, J. (2006). Predictive value of microabluminuria and proteinuria on cardiovascular and renal survival: A systematic review of cohort studies. XLIII ERA-EDTA congress.
  • Torres, D., Strippoli, G., Palmer, S., Schena, F., Craig, J. (2006). Predictive value of microalbuminuria and proteinuria on cardiovascular and renal survival: A systematic review of cohort studies. XLIII ERA-EDTA Congress, United Kingdom: Oxford University Press.
  • Strippoli, G., Craig, M., Schena, F., Craig, J. (2006). Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. Journal of the American Society of Nephrology, 17(4), S153-S155. [More Information]
  • Navaneethan, S., Pansini, F., Strippoli, G. (2006). Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials. PLoS Medicine, 3(5), e123 - 0615-e123 - 0618. [More Information]

2005

  • Strippoli, G., Craig, M., Craig, J. (2005). Antihypertensive agents for preventing diabetic kidney disease (Review). Cochrane Database of Systematic Reviews, 1(4), 1-46. [More Information]
  • Strippoli, G., Craig, M., Schena, F., Craig, J. (2005). Antihypertensive agents for primary prevention of diabetic nephropathy. Journal of the American Society of Nephrology, 16(10), 3081-3091. [More Information]
  • Strippoli, G., Bonifati, C., Craig, M., Schena, F., Craig, J. (2005). Antihypertensive agents for primary prevention of diabetic nephropathy: with focus on renal outcomes, is it proven that any agent is equivalent, as long as blood pressure control is tight? XLII Congress of the ERA-EDTA, United Kingdom: Oxford University Press.
  • Hodson, E., Craig, J., Strippoli, G., Webster, A. (2005). Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews, , 1-143. [More Information]
  • Hodson, E., Jones, C., Webster, A., Strippoli, G., Barclay, P., Kable, K., Vimalachandra, D., Craig, J. (2005). Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. The Lancet, 365(9477), 2105-2115. [More Information]
  • Hodson, E., Jones, C., Webster, A., Strippoli, G., Craig, J. (2005). Antiviral treatment after solid organ transplantation (Authors' reply). The Lancet, 366(9488), 807.
  • Rabindranath, K., Strippoli, G., Roderick, P., Wallace, S., MacLeod, A., Daly, C. (2005). Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. American Journal of Kidney Diseases, 45(3), 437-447. [More Information]
  • Strippoli, G., Craig, J., Rochtchina, E., Mitchell, P. (2005). Dialysis - nutrition, malnutrition, oxidative stress, inflammation 2: Poster (SP352) Daily intake of water, magnesium and carbohidrates associated with the development of renal impairment in the elderly. XLII Congress of the ERA-EDTA, United Kingdom: Oxford University Press.
  • Strippoli, G., Craig, J. (2005). Hypothesis versus association: the optimal hemoglobin target debate (Editorial). American Journal of Kidney Diseases, 46(5), 970-973. [More Information]
  • Palmer, S., Strippoli, G., McGregor, D. (2005). Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. American Journal of Kidney Diseases, 45(4), 638-649. [More Information]
  • Huynh, S., Kifley, A., Strippoli, G., Mitchell, P. (2005). Is renal impairment a predictor of the incidence of cataract or cataract surgery? Findings from a population-based study. Ophthalmology, 112(2), 293-300. [More Information]

2004

  • Strippoli, G., Tong, A., Johnson, D., Schena, F., Craig, J. (2004). Antimicrobial Agents For Preventing Peritonitis In Peritoneal Dialysis Patients. Cochrane Database of Systematic Reviews, 4, 1-79.
  • Strippoli, G., Tong, A., Johnson, D., Schena, F., Craig, J. (2004). Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trial. American Journal of Kidney Diseases, 44(4), 591-603.
  • Strippoli, G., Tong, A., Johnson, D., Schena, F., Craig, J. (2004). Catheter related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Journal of the American Society of Nephrology, 15(10), 2735-2746. [More Information]
  • Strippoli, G., Tong, A., Johnson, D., Schena, F., Craig, J. (2004). Catheter Type, Placement And Insertion Techniques For Preventing Peritonitis In Peritoneal Dialysis Patients (Review). Cochrane Database of Systematic Reviews, 4, 1-54.
  • Strippoli, G., Tong, A., Johnson, D., Craig, J., Schena, F. (2004). Catheter-Related Interventions To Prevent Peritonitis In Peritoneal Dialysis: A Systematic Review Of Randomized, Controlled Trials. Journal of the American Society of Nephrology, 15(10), 2735-2746.
  • Strippoli, G., Jonathan, C. (2004). Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers to prevent end-stage kidney disease in patients who do not have diabetes. Medical Journal of Australia, 181(8). [More Information]
  • Strippoli, G., Craig, M., Deeks, J., Schena, F., Craig, J. (2004). Effects Of Angiotensin Converting Enzyme Inhibitors And Angiotensin Ii Receptor Antagonists On Mortality And Renal Outcomes In Diabetic Nephropathy: Systematic Review. BMJ: British Medical Journal, 329 (7470)(828), 1-11.
  • Craig, J., Strippoli, G., Manno, C., Schena, F. (2004). Hemoglobin Targets For The Anemia Of Chronic Kidney Disease: A Meta-Analysis Of Randomized, Controlled Trials. Journal of the American Society of Nephrology, 15(12), 3154-3165.
  • Samuels, J., Schena, F., Strippoli, G., Craig, J., Molony, D. (2004). Immunosuppressive Treatments For Immunoglobin A Nephropathy: A Meta-Analysis Of Randomized Controlled Trials. Nephrology, 9(4), 177-185.
  • Samuels, J., Strippoli, G., Craig, J., Schena, F., Molony, D. (2004). Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology, 9(4), 177-185. [More Information]
  • Manno, C., Strippoli, G., Arnesano, L., Bonifati, C., Campobasso, N., Gesualdo, L., Schena, F. (2004). Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney International, 66(4), 1570-1577. [More Information]
  • Gesualdo, L., Di Palma, A., Morrone, L., Strippoli, G., Schena, F. (2004). The Italian experience of the national registry of renal biopsies. Kidney International, 66(3), 890-894. [More Information]
  • Strippoli, G., Craig, J., Schena, F. (2004). The Number, Quality And Coverage Of Randomized Controlled Trials In Nephrology. Journal of the American Society of Nephrology, 15(2), 411-419.
  • Flanc, R., Roberts, M., Strippoli, G., Chadban, S., Kerr, P., Atkins, R. (2004). Treatment For Lupus Nephritis. Cochrane Database of Systematic Reviews, 1(CD002922), 1-79.
  • Flanc, R., Roberts, M., Strippoli, G., Chadban, S., Kerr, P., Atkins, R. (2004). Treatment Of Diffuse Proliferative Lupus Nephritis: A Meta-Analysis Of Randomized Controlled Trials. American Journal of Kidney Diseases, 43(2), 197-208.

2003

  • Strippoli, G., Manno, C., Schena, F. (2003). An "evidence-based" survey of therapeutic options for IgA nephropathy: Assessment and criticism. American Journal of Kidney Diseases, 41(6), 1129-1139. [More Information]
  • Strippoli, G., Craig, M., Schena, F., Craig, J. (2003). Delaying the progression of diabetic nephropathy with antihypertensive agents: a meta-analysis of randomised trials. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Strippoli, G., Manno, C., Schena, F., Craig, J. (2003). Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. Cochrane Database of Systematic Reviews, CD003967(1), 1-77.
  • Samuels, J., Strippoli, G., Craig, J., Schena, F., Molony, D. (2003). Immunosuppressive agents for treating IgA nephropathy. Cochrane Database of Systematic Reviews, 4(Issue 4), 1-51. [More Information]
  • Strippoli, G., Craig, M., Schena, F., Craig, J., et, A. (2003). Improved survival with ACE inhibitors compared with angiotensin II receptor antagonists in patients with diabetic nephropathy. Journal of the American Society of Nephrology, 14, 6A-6A.

2002

  • Strippoli, G., Craig, J., Craig, M., Schena, F. (2002). Antihypertensive agents for preventing diabetic nephropathy and retarding its progression: a systematic review of randomized controlled trials [RCTs]. 3rd Annual Scientific Meeting of the Australian and New Zealand Association of Clinical Anatomists, Melbourne: La Trobe University.
  • Strippoli, G., Craig, J., Manno, C., et, A. (2002). Hemoglobin and hematocrit targets for the anemia of chronic renal failure: A systematic review of randomized trials. Journal of the American Society of Nephrology, 13, 632A.
  • Strippoli, G., Craig, J., Manno, C., et, A. (2002). Nephrology and randomized trials: Are we asking intervention questions? Are we asking them right? Journal of the American Society of Nephrology, 13, 4A.
  • Strippoli, G., Craig, J., Manno, C., Pertosa, G., Schena, F. (2002). Targets of anemia treatment in chronic renal failure. 3rd Annual Scientific Meeting of the Australian and New Zealand Association of Clinical Anatomists, Melbourne: La Trobe University.

To update your profile click here. For support on your academic profile contact .